Glycemic control and treatments in type 1 diabetes in childhood and adolescence in Portugal.
DOI:
https://doi.org/10.20344/amp.1651Abstract
The Pediatric Portuguese Society of Endocrinology and Diabetology established in 2001 a Study Group with the aim of investigate glycemic control, prevalence of microvascular complications and modalities of treatments in type1 diabetic patients.The cases for registration were those who were born between June 1, 1979 and June 1, 2001 (until 22 yr of age). A front sheet was constructed to record, age at diabetes diagnosis, diabetes duration, presence or absence of diabetes microvascular complications, HbA1c, number of capillary glycemic tests per week and type of insulin treatment.Twenty-two Hospitals participated and a total of 1009 patients were registered. The mean age was 13.6 yr+/-4.7, mean age at diabetes diagnosis 8.4 yr+/-4.4, and diabetes duration 5.2 yr+/-3.95. Diagnosis of diabetes was done in 22.8% by the age group 0-4 yr, in 36.4% by the age group 5-9 yr, in 32.4% by the age group 10-14, in 6.7% by the age group 15-19, and in 1.5% by the age group 20-22. Retinopathy was present in 1.4% and nephropathy in 6.4%. Values of HbA1c <7.5% were achieved in 12.5%, > or =7.5 and < 8% in 11.3%, > or =8 and <9.5 in 33.5% and > or =9.5 in 40.9%. Insulin treatment with one daily injection was used in 1.5%, with two daily injections in 35.4%, with three daily injections in 35% and with four or more in 26.4%.This study showed that this large cohort of type1 diabetic patients had a bad metabolic control and the goal of near normoglycemia was achieved in only a few patients.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
